AUTORES |
---|
INFECCIONES ESOFÁGICAS Y GASTROINTESTINALES INFECCIONES BILIOPANCREÁTICAS INFECCIONES INTRAABDOMINALES |
BIBLIOGRAFÍA |
---|
1. Wilcox CM. Overview of infectious esophagitis. Gastroenterol Hepatol. 2013; 9: 517 2. Rosołowski M, Kierzkiewicz M. Etiology, diagnosis and treatment of infectious esophagitis. Prz Gastroenterol. 2013;8(6):333-7. 3. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503–35. 4. Hoversten P, Kamboj AK, Wu TT, Katzka DA. Risk Factors, Endoscopic Features, and Clinical Outcomes of Cytomegalovirus Esophagitis Based on a 10-year Analysis at a Single Center. Clin Gastroenterol Hepatol. 2020 Mar;18(3):736-738. 5. Wang H-W, Kuo C-J, Lin W-R et al. Clinical characteristics and manifestation of herpes esophagitis. Medicine. 2016; 95: e3187. 6. Kim Y, Park K, Park D, Park J, Bang B, Lee S et al. Guideline for the abtibiotic use in acute gastroenteritis . Infect Chemother 2019 Jun;51(2): 217-243. 7. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, et al.Management of Helicobacter pylori infection—the Maastricht IV/Florence Consensus Report.Gut, 2012 (61): 646-664. 8. Gisbert JP,etal.IVConferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori. Gastroenterol Hepatol.2016. 9. Guirao X, Arias J, Badía JM, García-Rodriguz JA, Mensa J, Álvarez Lerma F , et al. Recomendaciones en el tratamiento antibiótico empírico de la infeccion intrabadominal . Cir Esp 2010; 87 (2): 63-81. 10. Sartelli M, Chichorm-Mefire A, Labricciosa FM, Hadcastle T, Abu-Zidan FM, Adesunkanmi A, et al. The management of intrabadominal infections from a global perspective: 2017 WSES guideline for management of intraabominal infections. World Journal of Emergency Surgery 2017 (12) : 29. 11. Baron TH, DiMaio CJ, Wang AY, Morgan KA. American Gastroenterological Association Clinical Practice Update: Management of Pancreatic Necrosis.Gastroenterology. 2020;158 (1) :67-75. 12. Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013;13 (4 Suppl 2):e1–15. 13. Yokoe M, Takada T, Mayumi T, Yoshida M, Isaji S, Wada K, et al. Japanese guidelines for the management of acute pancreatitis: Japanese guidelines 2015. J Hepatobiliary Pancreat Sci. 2015 (22) :405–32. 14. Leppäniemi, A., Tolonen, M., Tarasconi, A. et al. WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg 2019 Jun 13; 14: 27. 15. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrosis.J Hepatol. 2018; 69(2):406-460. 16. Wiest R, Krag A, Gerbes A. Spontaneous bacterial peritonitis: recentguidelines and beyond. Gut 2012; 61:297–310. 17. Fernandez J, Bert F, Nicolas-Chanoine MH. The challenges of multi-drug-resistance in hepatology. J Hepatol 2016; 65:1043–1054. |